Multivessel disease in primary percutaneous coronary intervention

G Belli1, P Presbitero

  • 1Humanitas Clinical Institute, IRCCS, Milan, Italy. guido.belli@humanitas.it

Insights

Percutaneous coronary intervention (PCI) is standard for acute myocardial infarction (AMI). Treating multivessel disease during primary PCI is complex, impacting long-term cardiac events and mortality.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Disease

Background:

  • Primary percutaneous coronary intervention (PCI) is the standard treatment for acute transmural myocardial infarction (AMI).
  • Approximately 50% of AMI patients present with multivessel (MV) coronary artery disease.
  • MV disease in AMI is linked to negative prognostic factors and increased long-term mortality.

Purpose of the Study:

  • To review clinical data on the treatment of MV coronary artery disease diagnosed during primary PCI for AMI.
  • To discuss the challenges in decision-making for treating non-culprit lesions in AMI.
  • To summarize current understanding of early atherosclerosis progression post-AMI.

Main Methods:

  • Review of available clinical data and studies.
  • Analysis of prognostic factors associated with MV disease in AMI.
  • Examination of short-term atherosclerosis progression after AMI.

Main Results:

  • Multivessel coronary artery disease in AMI patients is associated with adverse cardiac events and increased mortality.
  • Treatment of non-culprit lesions during primary PCI presents a complex clinical decision.
  • Understanding of early atherosclerosis progression after AMI is crucial for management.

Conclusions:

  • The management of multivessel coronary artery disease in the context of primary PCI for AMI requires careful consideration.
  • Further research is needed to optimize treatment strategies for these complex patients.
  • Addressing non-culprit lesions may impact long-term outcomes in AMI survivors.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...